Trump's quest to reduce drug prices is heating up. But will he be able to do it?

President Donald Trump is ramping up the heat on pharmaceutical companies, urging them in letters sent Thursday to cut down drug prices in accordance with an executive order he signed in May. But Trump has limited authority to actually force drug companies to adjust prices, according to experts, and his effort equates to price control. As a result, utilizing public pressure through these letters may be one tool he’s employing to get companies to comply, according to Benedic Ippolito, a senior fellow in economic policy studies at the conservative-leaning American Enterprise Institute think tank